Companies you'll love to work for

1up Health is revolutionizing healthcare interoperability through its modern data platform, which enables secure and compliant exchange of health data. The company offers a suite of products including the 1up FHIR Platform, 1up Patient Connect, and 1up Analyze, designed to facilitate data aggregation, integration, and analytics for payers, providers, and life sciences. With over 80 enterprise customers, 1up Health stands out for its unparalleled expertise in FHIR APIs and its commitment to meeting CMS interoperability requirements. The platform's cloud-based architecture allows for flexible data ingestion and superior data quality controls, making it a leader in the healthcare data management space.

ABK Biomedical is a clinical-stage medical device company focused on researching, developing, and commercializing innovative therapies for treating liver tumors. Their key products include Eye90 microspheres®, which utilize a proprietary imageable glass composition for Y90 radioembolization, and Easi-Vue™ embolic microspheres for direct visualization during embolization procedures. The company differentiates itself through its advanced technology and commitment to improving patient outcomes, having raised significant funding and achieved FDA designations for its products. With a strong leadership team and a focus on R&D, ABK Biomedical is well-positioned in the oncology market.

Adcentrx Therapeutics is a clinical-stage biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases. The company aims to create next-generation targeted therapies that combine the precision of biologics with the efficacy of small molecule payloads, addressing significant unmet medical needs in oncology. With a strong pipeline and recent FDA clearances for investigational drugs, Adcentrx is positioned to make a meaningful impact in the treatment landscape for advanced solid tumors.

Adela is pioneering advanced technology for cancer detection through blood tests, focusing on minimal residual disease (MRD) testing and early cancer identification. Their patented cf Me DIP-seq platform enhances test performance by capturing extensive genomic information, making it applicable across various cancers. With a mission to improve cancer care, Adela's innovative approach is set to transform treatment decisions and patient outcomes, positioning them as a leader in the oncology diagnostics market.

Aera Therapeutics is a biotechnology company focused on harnessing the power of genetic medicines through its proprietary protein nanoparticle (PNP) delivery platform. This innovative platform utilizes endogenous human proteins to create capsid-like structures that package and transfer nucleic acid cargo, addressing the limitations of current delivery technologies. Aera aims to expand the reach of genetic medicines across various therapeutic areas, thereby benefiting a broader patient population. The company is led by a distinguished team of industry leaders and scientists, positioning itself as a key player in the genetic medicine landscape.

Affinia Therapeutics is a pioneering company in gene therapy, focusing on developing innovative adeno-associated virus (AAV) vectors to treat rare and prevalent diseases. Utilizing their proprietary ART (Affinia Rationally-designed Therapies) platform, they leverage AI and structural modeling to enhance the targeting and effectiveness of gene therapies, particularly for heart and nervous system diseases. With a team experienced in drug development and a commitment to patient-centered solutions, Affinia aims to set a new standard in gene therapy, expanding its reach to address significant unmet medical needs.

Albert Invent is a cloud-based end-to-end R&D platform designed for the materials science industry, empowering thousands of scientists across 30+ countries to expedite innovation. The platform integrates electronic lab notebooks (ELN), laboratory information management systems (LIMS), and AI tools to enhance collaboration, data management, and regulatory compliance. With a focus on sustainability and customer success, Albert Invent aims to revolutionize chemical research by providing a unified solution that accelerates product development and reduces inefficiencies in R&D processes.

Alluvial is the software development company supporting the development of the Liquid Collective protocol. We're focused on the overall growth and maturity of the ecosystem by fostering participation in proof of stake blockchains.

Amber Therapeutics is pioneering the first adaptive neuromodulation therapy for women suffering from mixed urinary incontinence. Their flagship product, the Picostim TM System, is a fully implantable device that targets the pudendal nerve, providing personalized treatment by dynamically adapting to the patient's physiological responses. With a significant market need—40 million women in the US affected by urinary incontinence and only 16 million receiving therapy—Amber's innovative approach addresses both urge and stress incontinence, setting it apart from existing therapies. The company has demonstrated promising results in its AURA-2 study, showcasing safety and efficacy, and aims to transform the quality of life for millions of women globally.

Amplify MD is a leading virtual care solution for hospitals, providing integrated virtual care across specialties and care settings. Their platform enhances efficiency, making providers up to 2X more effective, while offering access to a built-in network of specialists in over 15 fields. The company addresses critical gaps in specialty coverage, enabling hospitals to manage telehealth services seamlessly across multiple EHRs. With a focus on improving clinical and financial outcomes, Amplify MD has demonstrated significant results, including a reduction in patient transfers and readmission rates, positioning itself as a key player in the virtual care market.

Applied VR is a pioneering company in immersive therapeutics, focusing on transforming chronic pain and mental health treatment through virtual reality. Their flagship product, Relie VRx, empowers patients to manage pain through evidence-based techniques, offering a drug-free alternative to traditional treatments. With a commitment to scientific rigor and patient-centered care, Applied VR aims to establish itself as the leading digital pain management platform, addressing the needs of millions suffering from chronic pain. The company has garnered attention for its innovative approach and is positioned to make a significant impact in the healthcare industry.

Argyle is a payroll connectivity platform that provides modern financial services by enabling businesses to automate income and employment verifications, background checks, fund accounts, and switch direct deposits. The platform leverages direct-source data to enhance operational efficiency, reduce costs, and improve customer experiences across various industries including mortgage, personal lending, and banking. With a focus on reliability, scalability, and security, Argyle positions itself as a leader in the market, serving a diverse clientele from startups to Fortune 500 companies, and processing over 150,000 verifications per month.